Total Payments
$13,773
2024 Payments
$1,272
Companies
61
Transactions
791
Medicare Patients
5,404
Medicare Billing
$417,472
Payment Breakdown by Category
Food & Beverage$13,768 (100.0%)
Education$5.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,768 | 790 | 100.0% |
| Education | $5.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,543 | 78 | $0 (2024) |
| ABBVIE INC. | $1,301 | 64 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,217 | 66 | $0 (2024) |
| Lilly USA, LLC | $974.81 | 59 | $0 (2024) |
| GlaxoSmithKline, LLC. | $836.42 | 58 | $0 (2023) |
| Novo Nordisk Inc | $732.73 | 51 | $0 (2024) |
| Amarin Pharma Inc. | $682.95 | 48 | $0 (2022) |
| Allergan, Inc. | $615.41 | 53 | $0 (2020) |
| PFIZER INC. | $528.94 | 34 | $0 (2024) |
| Amgen Inc. | $523.75 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,272 | 63 | PFIZER INC. ($248.26) |
| 2023 | $1,603 | 81 | AstraZeneca Pharmaceuticals LP ($234.11) |
| 2022 | $2,246 | 121 | Biohaven Pharmaceutical Holding Company Ltd. ($480.50) |
| 2021 | $2,516 | 143 | AbbVie Inc. ($513.24) |
| 2020 | $1,211 | 80 | Allergan, Inc. ($210.47) |
| 2019 | $1,729 | 99 | Shire North American Group Inc ($237.26) |
| 2018 | $1,954 | 120 | AbbVie, Inc. ($217.65) |
| 2017 | $1,242 | 84 | Novo Nordisk Inc ($171.18) |
All Payment Transactions
791 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: PAIN | ||||||
| 12/06/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $21.52 | General |
| Category: Endocrinology | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: PAIN | ||||||
| 11/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: UROLOGY | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: PAIN | ||||||
| 10/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: PAIN | ||||||
| 09/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: PAIN | ||||||
| 09/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: ANTIBIOTIC | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: PAIN | ||||||
| 08/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Diabetes | ||||||
| 06/23/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,461 | 56,904 | $335,365 | $123,944 |
| 2022 | 12 | 1,420 | 5,799 | $246,368 | $104,026 |
| 2021 | 12 | 1,344 | 6,729 | $252,373 | $116,814 |
| 2020 | 10 | 1,179 | 52,170 | $215,985 | $72,689 |
Total Patients
5,404
Total Services
121,602
Medicare Billing
$417,472
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 305 | 941 | $136,345 | $56,111 | 41.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 301 | 483 | $77,280 | $37,945 | 49.1% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 13 | 1,320 | $34,980 | $14,299 | 40.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 257 | 974 | $24,350 | $9,407 | 38.6% |
| J2010 | Injection, lincomycin hcl, up to 300 mg | Office | 2023 | 174 | 347 | $5,205 | $2,335 | 44.9% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 15 | 840 | $8,820 | $1,845 | 20.9% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 13 | 48,800 | $24,400 | $1,084 | 4.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 26 | $1,820 | $263.52 | 14.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 248 | 2,678 | $10,043 | $223.65 | 2.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 24 | 139 | $1,390 | $160.44 | 11.5% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 15 | 26 | $832.00 | $155.48 | 18.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 70 | 330 | $9,900 | $114.59 | 1.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 298 | 929 | $124,895 | $55,755 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 294 | 454 | $72,640 | $34,975 | 48.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 241 | 906 | $22,650 | $8,941 | 39.5% |
| J2010 | Injection, lincomycin hcl, up to 300 mg | Office | 2022 | 171 | 348 | $5,220 | $2,313 | 44.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 30 | $659.00 | $645.82 | 98.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 29 | 29 | $725.00 | $611.61 | 84.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 238 | 2,724 | $10,215 | $225.31 | 2.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 27 | 122 | $1,220 | $160.92 | 13.2% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2022 | 12 | 17 | $544.00 | $144.41 | 26.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $1,120 | $131.67 | 11.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 52 | 212 | $6,360 | $71.03 | 1.1% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 12 | 12 | $120.00 | $51.94 | 43.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 281 | 831 | $95,565 | $51,744 | 54.1% |
About Samuel Hale
Samuel Hale is a Family Medicine healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851369185.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Samuel Hale has received a total of $13,773 in payments from pharmaceutical and medical device companies, with $1,272 received in 2024. These payments were reported across 791 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($13,768).
As a Medicare-enrolled provider, Hale has provided services to 5,404 Medicare beneficiaries, totaling 121,602 services with total Medicare billing of $417,472. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lubbock, TX
- Active Since 03/11/2006
- Last Updated 06/02/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851369185
Products in Payments
- NURTEC ODT (Drug) $1,324
- TRINTELLIX (Drug) $916.62
- Vascepa (Drug) $682.95
- VRAYLAR (Drug) $668.14
- FARXIGA (Drug) $612.69
- UBRELVY (Drug) $560.21
- BREZTRI (Drug) $417.07
- Ozempic (Drug) $416.04
- TRELEGY ELLIPTA (Drug) $415.21
- MOUNJARO (Drug) $405.74
- VYVANSE (Drug) $383.18
- XIFAXAN (Drug) $326.64
- Azstarys (Drug) $250.87
- Prolia (Biological) $233.54
- EMGALITY (Drug) $222.72
- AZSTARYS (Drug) $210.32
- TRULICITY (Drug) $207.10
- SYMBICORT (Drug) $204.77
- SHINGRIX (Biological) $179.10
- Livalo (Drug) $176.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lubbock
Dr. Michael Mendez, M.d, M.D
Family Medicine — Payments: $273,840
Family Medicine $273,840
Dr. Robert Ordonez, M.d, M.D
Family Medicine — Payments: $22,971
Family Medicine $22,971
Randy Rozean, Md, MD
Family Medicine — Payments: $13,047
Family Medicine $13,047
Joel Landry, Md, MD
Family Medicine — Payments: $12,105
Family Medicine $12,105
Dr. Craig Barker, Md, MD
Family Medicine — Payments: $12,094
Family Medicine $12,094
Dr. Kompal Parmar, M.d, M.D
Family Medicine — Payments: $11,658
Family Medicine $11,658